Welcome to our cleanroom blog where we keep you informed on recent updates in our business and cleanroom industry insights and updates.
Precision Cleanrooms recognizes an industry pattern entering into 2021…there is a clear rise in demand for rapid-deployed modular cleanrooms across the United States. Two contributing factors to this increased demand are: a surge in the developments of vaccines, therapeutics and PPE, and a general push for more domestic manufacturing.
It is important to understand the cleanroom industry to make an informed decision as to who to partner with on your next cleanroom project. Precision Cleanrooms is neither a manufacturer of any components, nor a distributor. We have a vast supplier network and can select the appropriate materials for our customers’ application. With our in-house engineering and project management resources, we provide a comprehensive, consultative design/build cleanroom solution, customized to meet the regulatory and performance requirements of any industry.
With the arrival of the Pandemic in 2020, cleanroom solutions are proving to play a key-role in our national response to the deadly virus. To date, there have been 8.8 Million Covid-19 cases and 227,000 deaths in the United States alone. It is undoubtedly of great importance that we develop vaccines, medicines, and other critical products rapidly. One example of how we can respond quickly is by taking advantage of modular cleanroom solutions that serve our Life Sciences industry.
As our nation’s top scientists work tirelessly to develop a COVID-19 vaccine, the federal government, R&D groups and the pharmaceutical industry are working collaboratively to ensure our supply chain is ready to scale up production to meet the tremendous demand. Creating billions of doses of a COVID-19 vaccine is a herculean task.
A new wave of supply chain localization efforts are being fast tracked to offset the disruption caused by Covid-19
Taking care of ourselves and others in these difficult times – together we will persevere and grow stronger
The future holds increased regulation and heightened production standards for the medical marijuana, Cannabis and CBD industries.
The updated standard highlights that particular attention will be focused on the device materials used, rationale for biocompatibility tests performed, the compatibility of these materials with biological tissues, and the impact of the manufacturing processes on the material properties.
Gearing Up for EU MDR How cleanroom bioburden...